Mirador Capital Partners LP Processa Pharmaceuticals, Inc. Transaction History

Mirador Capital Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	BUY	$0.24 - $0.53 $181 - $401	758 Added 4.04%	19,516 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.73 $751 - $1,246	-1,708 Reduced 8.35%	18,758 $9,000
Q1 2023 Apr 14, 2023	SELL	$0.41 - $1.3 $333 - $1,058	-814 Reduced 3.83%	20,466 $10,000
Q4 2022 Feb 09, 2023	BUY	$1.1 - $50.0 $23,408 - $1.06 Million	21,280 New	21,280 $23,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Mirador Capital Partners LP with notifications on news.